Kinetics of Citalopram in Elderly Patients

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1985 Jan 1

PMID 3929295

Citations 16

Authors

K Fredericson Overo

B Toft

L Christophersen

Affiliations

Soon will be listed here.

Abstract

The kinetics of the antidepressant drug citalopram, a specific 5-HT uptake inhibitor, has been investigated in 11 elderly patients (age 73-90) and compared to previous data from younger patients and volunteers. The recorded steady state citalopram levels of 140-545 nM after a once-daily 20-mg dose were up to four times higher than expected from data in younger patients and volunteers. The biological half-life (1.5-3.75 days) and estimated systemic clearance (0.08-0.3 1/min) also differed from data in younger individuals (1.5 days and 0.4 1/min, respectively). Clearance values generally decreased with increasing age. Drug/metabolite ratios were higher in patients with the longest half-lives and lowest citalopram clearance, indicating reduced metabolic activity. No reduction in renal clearance was indicated by urine data, obtained for two of the patients. The study suggests that daily doses of 5-20 mg give approximately the same steady state plasma levels in elderly patients as doses of 40 mg in younger, and that this is due to reduced rates of metabolism in the elderly.

Citing Articles

Alzheimer's Disease: Cellular and Pharmacological Aspects.

Aranda-Abreu G, Rojas-Duran F, Hernandez-Aguilar M, Herrera-Covarrubias D, Chi-Castaneda L, Toledo-Cardenas M Geriatrics (Basel). 2024; 9(4).

PMID: 39051250 PMC: 11270425. DOI: 10.3390/geriatrics9040086.

Population pharmacokinetics model for escitalopram in Chinese psychiatric patients: effect of CYP2C19 and age.

Liu S, Xiao T, Huang S, Li X, Kong W, Yang Y Front Pharmacol. 2022; 13:964758.

PMID: 35924062 PMC: 9340256. DOI: 10.3389/fphar.2022.964758.

A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitation.

Akil A, Bies R, Pollock B, Avramopoulos D, Devanand D, Mintzer J J Pharmacokinet Pharmacodyn. 2015; 43(1):99-109.

PMID: 26611790 PMC: 4720707. DOI: 10.1007/s10928-015-9457-6.

Tolerability and safety of fluvoxamine and other antidepressants.

Westenberg H, Sandner C Int J Clin Pract. 2006; 60(4):482-91.

PMID: 16620364 PMC: 1448696. DOI: 10.1111/j.1368-5031.2006.00865.x.

The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach.

Friberg L, Isbister G, Hackett L, Duffull S J Pharmacokinet Pharmacodyn. 2005; 32(3-4):571-605.

PMID: 16307209 DOI: 10.1007/s10928-005-0022-6.

References

Kragh-Sorensen P, Overo K, Petersen O, Jensen K, Parnas W . The kinetics of citalopram: single and multiple dose studies in man. Acta Pharmacol Toxicol (Copenh). 1981; 48(1):53-60. DOI: 10.1111/j.1600-0773.1981.tb01587.x. View

Busse E, Simpson D . Depression and antidepressants and the elderly. J Clin Psychiatry. 1983; 44(5 Pt 2):35-9. View

Fredricson Overo K . Kinetics of citalopram in man; plasma levels in patients. Prog Neuropsychopharmacol Biol Psychiatry. 1982; 6(3):311-8. DOI: 10.1016/s0278-5846(82)80181-4. View

Schulz P, Smith G, Giacomini K, Blaschke T . Amitriptyline disposition in young and elderly normal men. Clin Pharmacol Ther. 1983; 33(3):360-6. DOI: 10.1038/clpt.1983.46. View

Lamy P . Comparative pharmacokinetic changes and drug therapy in an older population. J Am Geriatr Soc. 1982; 30(11 Suppl):S11-9. DOI: 10.1111/j.1532-5415.1982.tb01351.x. View

Dawling S, Crome P, Braithwaite R, Lewis R . Nortriptyline therapy in elderly patients: dosage prediction after single dose pharmacokinetic study. Eur J Clin Pharmacol. 1980; 18(2):147-50. DOI: 10.1007/BF00561582. View

Boeck V, Jorgensen A, Fredricson Overo K . Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels. Psychopharmacology (Berl). 1984; 82(4):275-81. DOI: 10.1007/BF00427669. View

Cutler N, Zavadil 3rd A, Eisdorfer C, Ross R, Potter W . Concentrations of desipramine in elderly women. Am J Psychiatry. 1981; 138(9):1235-7. DOI: 10.1176/ajp.138.9.1235. View

Veith R . Depression in the elderly: pharmacologic considerations in treatment. J Am Geriatr Soc. 1982; 30(9):581-6. DOI: 10.1111/j.1532-5415.1982.tb05668.x. View

10.

Ochs H . [The effect of age, weight, sex and smoking habits on drug dosage]. Internist (Berl). 1983; 24(3):167-81. View

11.

Boeck V, Overo K, Svendsen O . Studies on acute toxicity and drug levels of citalopram in the dog. Acta Pharmacol Toxicol (Copenh). 1982; 50(3):169-74. DOI: 10.1111/j.1600-0773.1982.tb00959.x. View

12.

Overo K . Preliminary studies of the kinetics of citalopram in man. Eur J Clin Pharmacol. 1978; 14(1):69-73. DOI: 10.1007/BF00560260. View

13.

Pedersen O, Kragh-Sorensen P, Bjerre M, Overo K, Gram L . Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study. Psychopharmacology (Berl). 1982; 77(3):199-204. DOI: 10.1007/BF00464566. View

14.

Turbott J, Norman T, Burrows G, Maguire K, Davies B . Pharmacokinetics of nortriptyline in elderly volunteers. Commun Psychopharmacol. 1980; 4(3):225-31. View

15.

Jusko W, Gibaldi M . Effects of change in elimination on varous parameters of the two-compartment open model. J Pharm Sci. 1972; 61(8):1270-3. DOI: 10.1002/jps.2600610820. View

16.

Gastpar M, Gastpar G . Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant. Prog Neuropsychopharmacol Biol Psychiatry. 1982; 6(3):319-25. DOI: 10.1016/s0278-5846(82)80182-6. View

17.

Nies A, Robinson D, Friedman M, Green R, Cooper T, RAVARIS C . Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry. 1977; 134(7):790-3. DOI: 10.1176/ajp.134.7.790. View

18.

Thompson 2nd T, Moran M, Nies A . Drug therapy: Psychotropic drug use in the elderly (first of two parts). N Engl J Med. 1983; 308(3):134-8. DOI: 10.1056/NEJM198301203080305. View

19.

Gottlieb P, Wandall T, Overo K . Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171). Acta Psychiatr Scand. 1980; 62(3):236-44. DOI: 10.1111/j.1600-0447.1980.tb00611.x. View

20.

Hyttel J . Citalopram--pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuropsychopharmacol Biol Psychiatry. 1982; 6(3):277-95. DOI: 10.1016/s0278-5846(82)80179-6. View